Version for the visually impaired:
Font size:
a
a
a

Preclinical studies of the innovative drug on the basis of hexaazaizowurtzitane derivative for the treatment of pain syndrome caused by different etiology

  • Main
  • Preclinical studies of the innovative drug on the basis of hexaazaizowurtzitane derivative for the treatment of pain syndrome caused by different etiology

The aim of the project was to conduct preclinical studies of the drug on the basis of hexaazaizowurtzitane derivative for the treatment of pain syndrome caused by different etiology. The evaluated analgesic appeared to be unique in the scope of the patent and scientific-medical literature on the complex of technological experimental-industrial decisions, effectiveness and safety. All the necessary preclinical studies were completed, the technology for the production of the substance and dosage form was developed, the documents for registration and clinical research were prepared. The development of the economically affordable domestic drug of Thiowurtzine capcule dosage form – innovative effective and low-toxic analgesic gave the opportunity to increase the effectiveness and safety of the treatment of different nosologies, injuries and surgeries accompanied by pain syndrome, to create on the territory of the Russian Federation high-technology pharmaceutical production with high export potential.